IDXX
IDEXX Laboratories, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$532.70
+0.64%Margins
Gross margin
62.4%
EBITDA margin
35.5%
EBIT margin
32.0%
Net margin
25.0%
FCF margin
27.5%
70.7%
Return on equity
33.1%
Return on assets
53.8%
Return on invested capital
1.33x
Asset turnover
$1.4B
Cash from operations
$2.50
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026